SBIR/STTR Award attributes
Embody, Inc has pioneered a breakthrough, scalable, additive biomanufacturing approach of hybrid electrospinning and pneumatospinning to engineer a collagen-based construct designed to promote new, aligned tendon-like tissue growth at the tendon implant site. This means the TAPESTRY implant helps the patient’s body to grow the correct new cells which eventually infiltrate and replace the implant entirely. The result is complete healing by the patient’s own cells—no implant remains. Unlike traditional materials in competitor products, TAPESTRY’s bioengineering creates an implant which mimics the cellular structure of the patient’s native tissue. Under this Phase II effort, Embody, Inc. will perform R&D/RDTE to advance the performance envelope of TAPESTRY by developing, prototyping, and testing arthroscopic instrumentation necessary for minimally invasive repair of the gluteus medius tendon using the TAPESTRY implant. The mission impact of this effort will enable surgeons to perform state-of-the art tendon and ligament repairs that reduce recovery time and re-injury rate.
